Combined assessment of gastric mucosal damage associated with Helicobacter pylori infection in children by virulence factors and pepsinogen

Cui-Lan HUANG, Qiong LIN

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 722-728.

PDF(1169 KB)
PDF(1169 KB)
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 722-728. DOI: 10.7499/j.issn.1008-8830.2504085
CLINICAL RESEARCH

Combined assessment of gastric mucosal damage associated with Helicobacter pylori infection in children by virulence factors and pepsinogen

Author information +
History +

Abstract

Objective To investigate the value of combining Helicobacter pylori (HP) virulence factor typing with pepsinogen (PG) in assessing HP infection-related gastric mucosal injury in children. Methods A cross-sectional study enrolled children presenting with gastrointestinal symptoms at Wuxi Children's Hospital from August 2023 to December 2024. Based on gastroscopic pathology, participants were assigned to a mild injury group (n=66) or a moderate/severe injury group (n=51). Serum PG levels and HP virulence factor typing (type I/II) were examined to evaluate the diagnostic performance of combined testing for mucosal injury severity. Results The moderate/severe injury group had higher serum PGI and PGII levels than the mild injury group (P<0.05), and type I HP infection predominated (85.7%). Receiver operating characteristic curve analysis showed the following diagnostic performance for moderate/severe gastric mucosal injury: type I HP plus PGI positivity yielded an area under the curve (AUC) of 0.781, specificity 62.1%, and sensitivity 82.4%; type I HP plus PGII positivity yielded an AUC of 0.742, specificity 90.9%, and sensitivity 47.1%; simultaneous positivity for type I HP, PGI, and PGII yielded an AUC of 0.775, specificity 60.6%, and sensitivity 82.4%. Conclusions Serum PG levels and type I HP infection are closely associated with gastric mucosal injury severity. Their combined detection demonstrates good diagnostic performance for grading injury severity and provides a noninvasive strategy for clinical assessment of HP-related gastric mucosal damage in children.

Key words

Gastric mucosal injury / Helicobacter pylori / Virulence factor / Pepsinogen / Child

Cite this article

Download Citations
Cui-Lan HUANG , Qiong LIN. Combined assessment of gastric mucosal damage associated with Helicobacter pylori infection in children by virulence factors and pepsinogen[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(6): 722-728 https://doi.org/10.7499/j.issn.1008-8830.2504085

References

[1]
Li Y, Choi H, Leung K, et al. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2023, 8(6): 553-564. DOI: 10.1016/S2468-1253(23)00070-5 .
[2]
Borka Balas R, Meliț LE, Mărginean CO. Worldwide prevalence and risk factors of Helicobacter pylori infection in children[J]. Children (Basel), 2022, 9(9): 1359. PMCID: PMC9498111. DOI: 10.3390/children9091359 .
[3]
公金铭, 孙立锋. 中国儿童幽门螺杆菌感染流行病学与耐药现状及其治疗进展[J]. 国际儿科学杂志, 2024, 51(5): 297-301. DOI: 10.3760/cma.j.issn.1673-4408.2024.05.003 .
[4]
Othman KI, Balaky STJ. Investigating the potential association of Helicobacter pylori cagA, vacA s1/s2, iceA1, iceA2, babA2, sabA, and oipA genotypes with gastric disease severity[J]. Cell Mol Biol (Noisy-le-grand), 2025, 71(1): 88-95. DOI: 10.14715/cmb/2025.70.1.9 .
[5]
Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms[J]. Braz J Microbiol, 2022, 53(1): 33-50. PMCID: PMC8731681. DOI: 10.1007/s42770-021-00675-0 .
[6]
Okuda M, Lin Y, Mabe K, et al. Serum pepsinogen values in Japanese junior high school students with reference to Helicobacter pylori infection[J]. J Epidemiol, 2020, 30(1): 30-36. PMCID: PMC6908843. DOI: 10.2188/jea.JE20180119 .
[7]
中华医学会病理分会消化病理学组筹备组. 慢性胃炎及上皮性肿瘤胃黏膜活检病理诊断共识[J]. 中华病理学杂志, 2017, 46(5): 289-293. DOI: 10.3760/cma.j.issn.0529-5807.2017.05.001 .
[8]
Su P, Li Y, Li H, et al. Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China[J]. Helicobacter, 2013, 18(4): 274-279. DOI: 10.1111/hel.12046 .
[9]
Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis[J]. Gut, 2015, 64(9): 1353-1367. PMCID: PMC4552923. DOI: 10.1136/gutjnl-2015-309252 .
[10]
Ren JS, Kamangar F, Qiao YL, et al. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort[J]. Gut, 2009, 58(5): 636-642. PMCID: PMC2792746. DOI: 10.1136/gut.2008.168641 .
[11]
Samuels TL, Johnston N. Pepsin, mucosal injury, and pathophysiology of non-acid reflux[J]. Otolaryngol Clin North Am, 2025, 58(3): 415-432. DOI: 10.1016/j.otc.2025.01.006 .
[12]
He Q, Liu L, Wei J, et al. Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review[J]. Cell Death Discov, 2022, 8(1): 158. PMCID: PMC8979943. DOI: 10.1038/s41420-022-00962-1 .
[13]
Qin Y, Geng JX, Huang B. Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases [J]. World J Gastrointest Oncol, 2023, 15(7): 1174-1181. PMCID: PMC10401465. DOI: 10.4251/wjgo.v15.i7.1174 .
[14]
Nguyen CL, Dao TT, Phi TN, et al. Serum pepsinogen: a potential non-invasive screening method for moderate and severe atrophic gastritis among an Asian population[J]. Ann Med Surg (Lond), 2022, 78: 103844. PMCID: PMC9207076. DOI: 10.1016/j.amsu.2022.103844 .
[15]
Wang H, Zhao M, Shi F, et al. A review of signal pathway induced by virulent protein CagA of Helicobacter pylori [J]. Front Cell Infect Microbiol, 2023, 13: 1062803. PMCID: PMC10140366. DOI: 10.3389/fcimb.2023.1062803 .
[16]
Saunders TL, Windley SP, Gervinskas G, et al. Exposure of the inner mitochondrial membrane triggers apoptotic mitophagy[J]. Cell Death Differ, 2024, 31(3): 335-347. PMCID: PMC10923902. DOI: 10.1038/s41418-024-01260-2 .
[17]
Nasier-Hussain M, Samanje JN, Mokhtari K, et al. Serum levels of oxidative stress, IL-8, and pepsinogen I/II ratio in Helicobacter pylori and gastric cancer patients: potential diagnostic biomarkers[J]. BMC Gastroenterol, 2025, 25(1): 2. PMCID: PMC11697901. DOI: 10.1186/s12876-024-03564-6 .
[18]
Nagasaki N, Takigawa H, Ito M, et al. Diagnostic performance of the normal range of gastrin calculated using strict criteria based on a combination of serum markers and pathological evaluation for detecting gastritis: a retrospective study[J]. BMC Gastroenterol, 2023, 23(1): 167. PMCID: PMC10199508. DOI: 10.1186/s12876-023-02816-1 .
[19]
Tong Y, Wu Y, Song Z, et al. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research[J]. BMC Gastroenterol, 2017, 17(1): 88. PMCID: PMC5520218. DOI: 10.1186/s12876-017-0641-6 .
[20]
庄琳琳, 王彩霞. 血清胃蛋白酶原与儿童幽门螺杆菌感染相关胃炎的关系[J]. 临床医学进展, 2024, 14(1): 219-226. DOI: 10.12677/ACM.2024.141032 .
[21]
Kim DU, Na JY, Paik SS, et al. Mucosal distribution of somatostatin-secreting gastric Delta cells in children with gastrointestinal reflux diseases[J]. Front Pediatr, 2023, 11: 1275842. PMCID: PMC10623155. DOI: 10.3389/fped.2023.1275842 .
[22]
Gottfried-Blackmore A, Namkoong H, Adler E, et al. Gastric mucosal immune profiling and dysregulation in idiopathic gastroparesis[J]. Clin Transl Gastroenterol, 2021, 12(5): e00349. PMCID: PMC8132986. DOI: 10.14309/ctg.0000000000000349 .
[23]
Zahir SO, El Khadir M, Boukhris SA, et al. Helicobacter pylori vacA allelic combination, dupA, cagE and cagA genotypes and their associations with gastric diseases in the moroccan population[J]. Jpn J Infect Dis, 2024, 77(6): 325-333. DOI: 10.7883/yoken.JJID.2024.061 .
[24]
Sultan AM, Shenouda R, Sultan AM, et al. The relation between host TLR9-1486T/C, rs187084 gene polymorphisms and Helicobacter pylori cagA, sodB, hsp60, and vacA virulence genes among gastric cancer patients[J]. Pol J Microbiol, 2022, 71(1): 35-42. PMCID: PMC9152911. DOI: 10.33073/pjm-2022-003 .
[25]
Xue Z, Li W, Ding H, et al. Virulence gene polymorphisms in Shandong Helicobacter pylori strains and their relevance to gastric cancer[J]. PLoS One, 2024, 19(9): e0309844. PMCID: PMC11383249. DOI: 10.1371/journal.pone.0309844 .
[26]
Kesharwani A, Dighe OR, Lamture Y. Role of Helicobacter pylori in gastric carcinoma: a review[J]. Cureus, 2023, 15(4): e37205. PMCID: PMC10163845. DOI: 10.7759/cureus.37205 .
[27]
Bhattacharjee A, Sahoo OS, Sarkar A, et al. Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity[J]. Infection, 2024, 52(2): 345-384. DOI: 10.1007/s15010-023-02159-9 .

Footnotes

所有作者声明无利益冲突。

PDF(1169 KB)

Accesses

Citation

Detail

Sections
Recommended

/